Tytuł pozycji:
Peritoneal dialysis vintage and glucose exposure but not peritonitis episodes drive peritoneal membrane transformation during the first years of PD
- Tytuł:
-
Peritoneal dialysis vintage and glucose exposure but not peritonitis episodes drive peritoneal membrane transformation during the first years of PD
- Autorzy:
-
Bartosova, Maria
Warady, Bradley A.
Ujszaszi, Akos
Schaefer, Franz
Vondrak, Karel
Dzierżęga, Maria
Milosevski-Lomic, Gordana
Taylan, Christina
Cerkauskiene, Rimante
Buscher, Rainer
Romero, Philipp
Lasitschka, Felix
Schmitt, Claus Peter
Sallay, Peter
Schaefer, Betti
Zaloszyc, Ariane
- Data publikacji:
-
2019
- Słowa kluczowe:
-
peritonitis
glucose degradation products
EMT
glucose
VEGF
TGF-ß
peritoneal membrane
peritoneal dialysis
- Język:
-
angielski
- Prawa:
-
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
http://creativecommons.org/licenses/by/4.0/legalcode.pl
- Dostawca treści:
-
Repozytorium Uniwersytetu Jagiellońskiego
-
The impact of peritoneal dialysis (PD) associated peritonitis on peritoneal membrane
integrity is incompletely understood. Children are particularly suited to address this
question, since they are largely devoid of preexisting tissue damage and life-style
related alterations. Within the International Peritoneal Biobank, 85 standardized parietal
peritoneal tissue samples were obtained from 82 children on neutral pH PD fluids with
low glucose degradation product (GDP) content. 37 patients had a history of peritonitis
and 16 of the 37 had two or more episodes. Time interval between tissue sampling
and the last peritonitis episode was 9 (4, 36) weeks. Tissue specimen underwent
digital imaging and molecular analyses. Patients with and without peritonitis were
on PD for 21.0 (12.0, 36.0) and 12.8 (7.3, 27.0) months (p = 0.053), respectively.
They did not differ in anthropometric or histomorphometric parameters [mesothelial
coverage, submesothelial fibrosis, blood, and lymphatic vascularization, leukocyte,
macrophage and activated fibroblast counts, epithelial-mesenchymal transition (EMT),
podoplanin positivity and vasculopathy]. VEGF and TGF-ß induced pSMAD abundance
were similar. Similar findings were also obtained after matching for age and PD vintage
and a subgroup analysis according to time since last peritonitis (<3, <6, >6 months).
In patients with more than 24 months of PD vintage, submesothelial thickness,
vessel number per mmm section length and ASMA fibroblast positivity were higher
in patients with peritonitis history; only the difference in ASMA positivity persisted in
multivariable analyses. While PD duration and EMT were independently associated with
submesothelial thickness, and glucose exposure and EMT with peritoneal vessel density
in the combined groups, submesothelial thickness was independently associated with EMT in the peritonitis free patients, and with duration of PD in patients with previous
peritonitis. This detailed analysis of the peritoneal membrane in pediatric patients on PD
with neutral pH, low GDP fluids, does not support the notion of a consistent long-term
impact of peritonitis episodes on peritoneal membrane ultrastructure, on inflammatory
and fibrotic cell activity and EMT. Peritoneal alterations are mainly driven by PD duration,
dialytic glucose exposure, and associated EMT.